Chronic inflammation — persistent, low-level immune activity — raises Alzheimer's risk most clearly in people with inherited risk. In people who carry the APOE4 gene variant, Framingham researchers found chronic inflammation linked to about six times higher Alzheimer's risk and much earlier onset. Family history signals that inherited risk. A parent or sibling with Alzheimer's raises personal concern because both shared family risk and genes such as APOE4 affect future risk.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What Family History Means for Your Risk
- Why Inflammation Matters More With APOE4
- What Routine Blood Markers Show
- What to Discuss With Your Clinician
What Family History Means for Your Risk
Harvard Health Publishing notes that having a first-degree relative with Alzheimer's increases personal dementia risk. Risk grows higher when more than one parent or sibling is affected Harvard family risk guidance. The same source explains that APOE4 is the major late-onset genetic risk factor: one copy roughly triples Alzheimer's risk, while two copies raise it about 10 to 15 times.
For example, one affected parent raises concern more than no family history. Two affected parents or siblings raise concern further. That pattern is why details about parents, siblings, and APOE4 matter together for personal risk.
Why Inflammation Matters More With APOE4
Framingham researchers tracked chronic low-grade inflammation using CRP at or above 8 mg/L. Among APOE4 carriers, those with that level had markedly higher Alzheimer's risk than carriers without inflammation.
The gap was large, with a hazard ratio of 6.63 for Alzheimer's and 3.52 for earlier onset, and no similar effect in APOE3 or APOE2 carriers JAMA Network Open analysis. Boston University researchers concluded that without chronic inflammation there might be little excess Alzheimer's risk from APOE4. They suggested rigorous treatment of systemic inflammation could aid prevention Boston University summary.
What Routine Blood Markers Show
In over 370,000 NYU Langone and Veterans Health patients, researchers linked higher neutrophil-to-lymphocyte ratio to higher dementia risk. The increase was 7% at NYU and 21% in veterans, with risk rising steadily as NLR rose NeurologyLive report on the NYU study.
NLR compares two types of white blood cells. A higher value signals more systemic inflammation. That makes it a useful risk signal to track over time, not a diagnosis by itself.
What to Discuss With Your Clinician
These are observational links, not proof that inflammation causes dementia. Boston University researchers advise people with family history to talk with a clinician about monitoring inflammation and controlling its sources.
Ask about these items at that visit: Bring recent lab results, blood pressure and blood sugar records, and a list of relatives with Alzheimer's. Ask what target ranges and follow-up timing fit your history.
- routine CRP and blood-count checks, including NLR trends
- control of cardiovascular disease, diabetes, and blood pressure
- prompt treatment of infections and other ongoing inflammatory sources
- which parents or siblings had Alzheimer's and at what ages
